Thin-strut drug-eluting stents in patients with challenging coronary lesions

Rosaly Anne Buiten

Research output: ThesisPhD Thesis - Research UT, graduation UT

112 Downloads (Pure)


Patients with symptomatic obstructive coronary artery disease are often treated with percutaneous coronary intervention; a procedure during which the occluded coronary artery is re-opened and a drug-eluting stent (DES) is placed in the narrowed vessel. This dissertation describes the clinical outcome of patients who participated in large-scale multicenter randomized clinical trials and were treated with a modern type of DES. The main clinical outcome included the assessment of safety and efficacy. All-comer patients treated with all four types of DES that were assessed in the trials showed excellent clinical results, until at least three years of follow-up. In specific subgroups of patients, i.e., in patients treated in coronary arteries with a small lumen vessel diameter (<2.5mm) and in patients treated in severely calcified coronary arteries, the thinnest DES and radiographically most visible DES showed the best clinical outcome. Furthermore, three years after stenting, the clinical results of patients treated in bifurcation lesions were encouraging without between-DES differences. In conclusion, modern DES seem to be safe and effective and there might be potential advantages for one stent over another in specific subgroups of patients.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • University of Twente
  • von Birgelen, Clemens, Supervisor
  • Doggen, Carine J.M., Supervisor
Award date19 Jun 2020
Place of PublicationEnschede
Print ISBNs978-90-365-4998-1
Publication statusPublished - 2020


Dive into the research topics of 'Thin-strut drug-eluting stents in patients with challenging coronary lesions'. Together they form a unique fingerprint.

Cite this